LATEST ALERTS
US cannabis rescheduling could eventually lead to companies saving around $2bn a year in federal taxes, a recent cannabis economics report claims, by allowing businesses to deduct their business expenses on their federal tax returns
This report provides detailed analysis of the regulatory framework in place in Canada for CBD and other cannabinoids, hemp, and cannabis (both recreational and medical)
The UK Advertising Standards Authority (ASA) does not appear to be especially concerned about the potential for mentioning the presence of CBD in a product being a health claim. The ASA recently made a ruling on Rebel Wines, a CBD-infused alcoholic beverage brand
This report provides a detailed analysis of the current regulatory framework in place for hemp, CBD and cannabis in Slovakia, covering all policy areas
Another major Canadian cannabinoid company is leaving the US market amid concerns over the regulatory environment some say the US Food and Drug Administration has caused
Cannabis companies in Italy are opposing a government decree that will become effective on 20th September and may outlaw CBD oils for oral use in the country
The US Department of Health and Human Services recommendation to reschedule cannabis to a less restrictive schedule could be the boon that the besieged cannabis industry needs
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
